Summary : Rigel Pharmaceuticals, Inc. Inducement Plan, as amended, with a grant date of January 6, 2022, as an inducement material to…
Biopharmaceutical
-
-
AgrochemicalsIndia
Maharashtra health minister Rajesh Tope inaugurates Bharat Serums and Vaccines’ R&D centre at Airoli
by adminby adminSummary : -Maharashtra health minister Rajesh Tope has inaugurated Bharat Serums and Vaccines (BSV)’s research and development centre at Airoli. -BSV, a…
-
AgrochemicalsIndia
Haryana sets up most number of Ayurvedic Manufacturing Units in 2020-21
by adminby adminSynopsis: The State of Haryana has seen the highest number of new companies manufacturing ayurvedic medicines registered during the fiscal year 2020-21,…
-
AstraZenecaGlobal Market
AstraZeneca, Neurimmune Sign Exclusive Collaboration and License Agreement for NI006
by adminby adminSynopsis: Neurimmune AG, a biopharmaceutical company, announced that it has entered into an exclusive global collaboration and license agreement with Alexion, AstraZeneca’s…
-
AgrochemicalsCovid DrugsIndia
Indomethacin highly efficacious in treating Covid infection: Study
by adminby adminIndomethacin is shown to be highly efficient in treating the Covid infection as per a study conducted by Dr Rajan Ravichandran, director…
-
Global MarketRegulatoryU.S FDA
US FDA clears Jubilant Therapeutics’ IND for novel dual LSD1 & HDAC6 inhibitor, JBI-802 for treatment of solid tumours
by adminby adminSynopsis: Jubilant Therapeutics Inc, a biopharmaceutical company, announced US Food and Drug Administration (FDA) clearance of the investigational new drug application (IND)…
-
Synopsis : This strain of the SARS-CoV-2 carries the N501Y mutation While the world is pulling in resources to fight back against…
-
AgrochemicalsGlobal Market
1000 Cr Approved by Wockhardt board to meet the Company’s Financing Needs
by adminby adminSynopsis: The objective of the issue is to meet the company’s financing needs for repayment of subordinated debt due, financing research and…
-
AgrochemicalsGlobal Market
AstraZeneca completes transfer of global rights to Eklira & Duaklir to Covis Pharma
by adminby adminSummary : AstraZeneca has completed the transfer of its global rights to Eklira (aclidinium bromide), known as Tudorza in the US, and…
-
RegulatoryU.S FDA
US FDA approves expanded MRI compatibility for Abbott’s Proclaim XR Spinal Cord Stimulation System
by adminby adminSummary : -Abbott, a global healthcare leader, announced that the US Food and Drug Administration (FDA) has approved new expanded magnetic resonance…